In this issue, Thiadens and colleagues report ophthalmoscopic findings of macular disruption and physiologic findings of cone-rod dystrophy in two of four cousins from a family with Danon disease, a rare X-linked disorder characterized by muscle weakness, cardiomyopathy, and mental impairment, which has been mapped to mutations in the lysosomeassociated membrane protein gene, LAMP2 (OMIM #300257) [1] .
Though descriptions of this disorder date from 1940 [2] , there are only a handful of reports in the literature of ocular abnormalities [3] [4] [5] [6] . The spectrum of the ocular findings remains unclear: the published reports are incomplete and the findings appear to differ markedly between families. For example, the report of LacosteCollin et al. [3] mentions "a diffuse chorio-capillary ocular atrophy," but presents no details or fundus images. Prall et al. [5] report a "peripheral pigmentary retinopathy," with "near-complete loss of pigment in the retinal pigment epithelium, " and show images of peppered pigmentary mottling in affected females and an asymptomatic carrier, and complete loss of RPE pigmentation in an affected male, but provide no images of the posterior pole. They report prolongation of ERG latencies, but mention no reductions in amplitude. Schorderet et al. [6] show much milder pigmentary disturbance in two affected males, and asymmetric reduction in multifocal ERG amplitudes in one patient.
In contrast, Thiadens et al. report predominantly central fundus abnormalities (a "bull's-eye maculopathy"), severe color vision disturbances, and a cone-rod pattern of amplitude reduction in the full-field ERG.
Their report is also of interest in expanding the spectrum of mutations linked to cone-rod dystrophies. OMIM lists at least 15 such disorders, of which three are X-linked. Of equal interest is the apparent variable expressivity in the present report, in which only two of four male cousins carrying the same LAMP2 mutation developed retinal symptoms.
Much remains to be learned about both cone-rod dystrophies and about Danon disease and the pathogenetic implications of LAMP2 mutations.
